Gelling Fibers Market Size, Share and Global Trend By Product Type(Gelling Fibre with Silver Ions, Gelling Fibres without Silver Ions), By Material Type(Carboxymethyl Cellulose (CMC), Polyvinyl Alcohol), By End User(Hospitals & Trauma Centers, Speciality Clinics, Ambulatory Surgery Centers ) and Regional Forecast, 2024-2032

Wound management is one of the most critical concerns in any healthcare environment. Gelling Fibres are now preferred in wound care instead of the traditional alginate fibers. Gelling fibers are soft, comfortable, non-woven absorbent wound covers which help in managing the drainage as well as removal of damaged, dead and infected tissues from the wound. The wound fluid is absorbed by the gelling fiber dressing, resulting in the formation of a gel which facilitates in maintaining a moist environment required for wound healing and creation of new tissues.

Gelling Fibres are capable of retaining and controlling the exudate level, which reduces the risk of peri-wound maceration and any other infections. Unlike other dressing fibers, gelling fibers can conform to the varying wound shapes and can be removed in one piece. Emerging government guidelines, strategic collaborations and new product introduction have resulted in a huge upsurge in the global gelling fiber market. In May 2018, FDA granted marketing approval to SURECELL, a gelling fiber product for wound care developed by Jiangsu Newvalue Medical Products Co., Ltd., which is expected to favor the global gelling fiber market. 

The growth of the global gelling fibers market is being driven by the increase in the prevalence of lacerations, post-operative surgical injuries & other types of wounds, and the introduction of new and advanced products. According to the National Centre for Injury Prevention and Control, the percentage contribution of injuries to total years of potential life lost before the age of 75 was 23.1%, in 2015. This increase in the number of injuries or wounds, in turn, implies growth in global gelling fibers market.

The availability of alternative products of dressing such as foams and alginate dressings, and the requirement of another secondary dressing while using gelling fibers are the factors hampering the growth in global gelling fibers market.

Key Players Covered 

Some of the major companies that are present in the global gelling fibers market are DermaRite Industries, LLC., Mölnlycke Health Care AB, Cardinal Health, Smith & Nephew, Gentell Corp., ConvaTec Inc., Crawford Healthcare Limited, Safe n' Simple, and others. 

 SEGMENTATION  

In terms of material, the Carboxymethyl Cellulose (CMC) segment is anticipated to hold a major portion of the global gelling fibers market during the forecast period, owing to the high usage of carboxymethyl cellulose for manufacturing gelling fibres when compared to polyvinyl alcohol

Key Insights 

• Prevalence of post-operative wounds – for key countries
• Overview of materials used for making gelling fibers
• Overview of alternative products in the market.
• Pricing analysis
• The regulatory scenario for key countries
• Key mergers and acquisitions 

Regional Analysis 

The global gelling fibers market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to have a major portion in the global gelling fibers market in the forecast period due to the emerging government guidelines for post-operative care, and use of gelling fibers for wound dressings. In Europe, the global gelling fibers market is projected to expand in the forecast duration, owing to the strategic collaborations of key companies and improving healthcare infrastructure. In June 2018, Acelity acquired Crawford Healthcare, a wound care company based in the U.K., in order to expand its product portfolio and strengthen its position in Europe. 

Key Industry Developments

• In November 2018, Mölnlycke Health Care AB announced to launch Mepilex Border Flex, the company product for wound dressing at the Symposium on Advanced Wound Care Fall meeting.
• In May 2018, FDA granted marketing approval to SURECELL, a gelling fiber product for wound care developed by Jiangsu Newvalue Medical Products Co., Ltd.
• In July 2016, Acelity launched BIOSORB, a gelling fiber for advanced wound management in the U.S. and received Conformité Européenne (CE) Mark in Europe.
• In June 2018, Acelity acquired Crawford Healthcare, a wound care company based in the U.K., in order to expand its product portfolio and strengthen its position.